"New accounts filed by Laya Healthcare Ltd show that pre-tax profits increased by 108pc from €9.13m in 2023 to €19.02m last year. This followed revenues rising by 2.5pc from €100.85m to €103.39m. Last year Laya imposed two premium price hikes on its customer base. In October 2024, it increased its premiums on average by 6.5pc, stating at the time that the price rise was needed to address the increased demand for healthcare services and rising costs."
"The directors state that this growth saw the company's membership base growing to over 717,000 members in 2024 from 696,000 in 2023 - an increase of 3pc. The directors state that the company's "Health and Wellness services also saw growth during the year, through the expansion of products and offerings to both our corporate and individual members"."
"The firm last year paid out dividends of €5m after a dividend payout of €25m in 2024. In a subsequent event, the directors state that Dermot Oliver O'Connor succeeded Dónal Clancy to assume the position of MD of the company on January 1st of this year. Last year was the first full year of the ownership of Laya Healthcare by French headquartered Axa following the €650m sale of Laya Healthcare by AIG subsidiary, Corebridge Financial to Axa in O"
Pre-tax profits rose by 108% from €9.13m in 2023 to €19.02m in 2024. Revenues increased by 2.5% from €100.85m to €103.39m. Multiple premium increases occurred, including a 7% rise in April 2024, a 6.5% average hike in October 2024, and further increases in April and October 2025 averaging 6.6% and 4.5%. Membership grew to over 717,000 members, up from 696,000, and Health and Wellness services expanded through additional products and offerings. Dividends of €5m were paid last year after €25m in 2024. Dermot Oliver O'Connor became MD on January 1st. Axa completed ownership following a €650m acquisition.
Read at Irish Independent
Unable to calculate read time
Collection
[
|
...
]